{"name":"Value Outcomes Ltd.","slug":"value-outcomes-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Vessel","genericName":"Vessel","slug":"vessel","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Vessel","genericName":"Vessel","slug":"vessel","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPTkxodlo3cnlZc0xmQkt5Ml9vcmkybVoyYlZIcTBCVzByblZtbWp3WTBsUjVyMko2bFA1YVpvVjlwUzV4S1c4MzR4ZXNvc3FDcTlrbUZqenBpMUlveEVVN2NjSHN4S0xIREFRZmtSaFRLQ0dVWTgzbkFyOHZlZWxZOWpjMmNvaEI5VTB1VGE1TEk3dDVqQVFlR3ZiQ2JscllISS1BbVM0TUxmcm9jWU5XS1d5NjhEWFdETGxPbUloMk9jZkZtTTJiYTlPQ0tROXZ6ZjVzUS1fNUJBSmRab3c?oc=5","date":"2026-04-06","type":"pipeline","source":"HLTH","summary":"Sound Outcomes: How Digital Therapies Are Impacting Value-Based Care for Providers, Pharma and Payers - HLTH","headline":"Sound Outcomes: How Digital Therapies Are Impacting Value-Based Care for Providers, Pharma and Payers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNS1BvcS03V0ZCVURVSFpNRGJ1cGI1MHlVVVhyMUcySTZuYU5LZzc0VENSV3lXSEJ1VzlFYm42TVk4VzNwaDlobUdmSVBPalp0eUg5ZmtQV3h5SVdZQ3BhcWJ1cEROOWdmd3Qwd3V6Njd0T3V6V2dlWlFMOC1YblgzSFpuakxTRWhWOWZXRnJBVERpbjl4UXVEYVZ6MGRYaXVKNEUzS21FU2pneEc4LWxFRWpiUDlNak56UkRpYVFJT08tUk1hcWlyQkd3dG9lZlJPQVBpamlwUFdGQQ?oc=5","date":"2026-03-24","type":"regulatory","source":"scanx.trade","summary":"NATCO Pharma Limited Board Meeting outcome regarding Scheme of Arrangement approval, subsidiary incorporation in Nigeria, and liquidation of Australian subsidiary under Regulation 30 - scanx.trade","headline":"NATCO Pharma Limited Board Meeting outcome regarding Scheme of Arrangement approval, subsidiary incorporation in Nigeria","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQZnptdnZFdFZRVWhWVDdMVHNhY19EU1hya0stZ2dDbHZoZnJNWExlSGF5bks2ejVsRjU2LXZpTW1sb0wtWFBWTG4zVXowc0tvd0NvcTVibU12R1JFVGs3MUhYeG4wX3J0dmg0WjNfQTV6NkxBVHQxTndyTEdnRHctMklHUQ?oc=5","date":"2026-03-11","type":"pipeline","source":"KFF","summary":"Key Facts About Medicare Drug Price Negotiation - KFF","headline":"Key Facts About Medicare Drug Price Negotiation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNazh2WTVKU1lfWmVSNjRONVFmTUh1TDZycU5CSGU0Q3ZCSW4yM0VONjktemk2QlRhdFFPaUFFdW5zQjZXWmxNaFcySlFTc05DRFVQcjg2b1pyYk1EbG92cDZWTXNkalJENGZ1bnRGTl9jUDBJMFVXa2hrbllyTkoxQ05HUEswZUtXNk16TmhvNWJvdG1RWXVINQ?oc=5","date":"2026-01-09","type":"pipeline","source":"PwC","summary":"Future of Pharma: Breakthroughs at Scale - PwC","headline":"Future of Pharma: Breakthroughs at Scale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPYzItSG9ZYjIyS2NnaUFmS0RucUZ4bE5vQTh0S2VTQWNYTmllbk9sRGdpM2I3YnZTbWhQd0d2NGlTejlJMU5wWGg2NE93YndTMXdSTlFMS181Ykl0MUljQTIyU3Y5QW1EWDlXdVcta3lkUS05YTBTREdyMmFSLUJNMmJPa055NGh6ZVFxdWk5Zw?oc=5","date":"2025-08-05","type":"pipeline","source":"Buchanan Ingersoll & Rooney","summary":"Major Update on GLP-1 Litigation involving Compounding Pharmacies - Buchanan Ingersoll & Rooney","headline":"Major Update on GLP-1 Litigation involving Compounding Pharmacies - Buchanan Ingersoll & Rooney","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPUDdBcUhhSTZ4eFYtMWlyUlozb296X1c3ZzVPQXNlTzRYTURzNzVoczFXMHBqNkpHTzBnWnM4YVZaZGlNM2FYWUdaekt1ZHV3SGNCcks2MmxrX2NUMWdfVy1rZHlqN3M2QnUzNGNtTEE1NkIxLW1sUElHUkd1Y1VKZlRJT3JHUmpUTDZvT3J2aDRfM1g4WE9oUHpjYnd4MzBCWGt4MF9CT2ppVi10MXpiTUtFY0M?oc=5","date":"2025-05-28","type":"pipeline","source":"Marsh","summary":"Drug warranties, outcome-based agreements, and barriers to costly therapies - Marsh","headline":"Drug warranties, outcome-based agreements, and barriers to costly therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOMXU1RDBTb2JFVXVZVmZ5am5zdTJJUkZ6bWh1VFRyQnE3TU85bG5VVHRwVUp3SDhMRzNwVDdLakZOOFJ1NHBhUTdLeDJhVnB6dmd2ZVFrYzhpdUFUeHBFampYOHFlVnZ2OTNkclMxSTh5TmFvZHZBeWxYS0FUeWwzRk5jWXNkUVBBN3V4Yk5R?oc=5","date":"2025-03-17","type":"pipeline","source":"Information Technology and Innovation Foundation (ITIF)","summary":"The Value of Follow-On Biopharma Innovation for Health Outcomes and Economic Growth - Information Technology and Innovation Foundation (ITIF)","headline":"The Value of Follow-On Biopharma Innovation for Health Outcomes and Economic Growth - Information Technology and Innovat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPNDhzelQ1M3RrZ1p4eS1aTjNucmlCR1l1NmF0OE0zd0hHSWlEQjlhQXB4RElaaklwM3FZY05ISXptYzNiMy1xMnFWcnEzMlg5UEM0cWoyVkFqM0RLR28yMTAzeUZWeUdDT2pEMXpZMFZXSDBrVUtwU1h1MlRpeVNhTw?oc=5","date":"2025-03-06","type":"pipeline","source":"Pharmaceutical Executive","summary":"HEOR: From Proving Product Value to Proving Its Own Worth - Pharmaceutical Executive","headline":"HEOR: From Proving Product Value to Proving Its Own Worth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOcHdrMnFpdHZZcG9nR21HeW9yZGQ1azcxWFFtZUNFNFh2S3M1MXNKY3NJZ2l0RUxpTTFHaHhhczJDYllrckt2SVNLLUtldC1CYkxMMW5MamtlMnNISU51MmtTTUVyR2tKYnlpVVNhS2JCWC1GcU5idVZMZlBaZmVNMWpyU3VMRnJVYnNKQkNONzJUU3JJ?oc=5","date":"2024-06-24","type":"pipeline","source":"Frontiers","summary":"Unraveling elements of value-based pricing from a pharmaceutical industry’s perspective: a scoping review - Frontiers","headline":"Unraveling elements of value-based pricing from a pharmaceutical industry’s perspective: a scoping review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOSTYwMHRpTlNGQ0M3X015YTJSWU1ia3B5S191dERZdnIwY0JwRXlhQ2VyTks1Q0NnN2pSb25kM3JjZVFYR3VrbTRkeGZXUWRhWXRNQnVjLVMwLUo4S0N0YUpBNEFHd1VzblQ5QVBCOHNwSXNDMTk5WktSeXgwQzJNUEszLTB4RGNFa0dnZXk0WWF4NEV0clI2dU5nVkVWX05vNFM5blVCYWFKaXJ0MHRtNnRLek5GSXdYbWswV3hRWFRuWFRkcURwSHQ1TDhxbjRkNWxjUktEdHNDS2Zzb2pYWVVyWGZqa0VVbjYzMTVzWFRqeDJjWHhyOQ?oc=5","date":"2023-06-05","type":"trial","source":"Cardinal Health","summary":"Cardinal Health announces the merger of its Outcomes™ business into Transaction Data Systems and related partnership - Cardinal Health","headline":"Cardinal Health announces the merger of its Outcomes™ business into Transaction Data Systems and related partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQVTdIQVR3OGRVM2tYWTlYQ3Z2MWJXNC1RSXJHd3I2QVVldG9xODM4NXp4OTBUNjcwNlliSE5nWFVmT2ZVNmx0VmJRYVVmVFN5VUczVTRzWE0tUE9WODU0THlYMFNPNnJFX0hTRjBBMzRBOElDRVFiNE5sNGxWeUV1SDJzUlNwN2lMUWk4ZFJBejJmYW1BeGFkell6MWdhMGpTUjNIY001ZzJTTzA5NEpnZlZ5enpNVEhlMXc?oc=5","date":"2021-09-13","type":"pipeline","source":"Center for American Progress","summary":"Value-Based Pricing of Prescription Drugs Benefits Patients and Promotes Innovation - Center for American Progress","headline":"Value-Based Pricing of Prescription Drugs Benefits Patients and Promotes Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE4yeGZqU2lGT0JwNlh2ZzRKWTNxNmE2VjRBOEdaU1FjM1JQanNTSkQ4SU1oUDhwYzJwNHp0eklDUmJsLXZPN1ZxTXctazBCdGM0V1c2WGdLbVZUOWhPcUw3WnVINlVDbzZDeGVCVFJrb1d0MGZhUEE?oc=5","date":"2020-01-30","type":"pipeline","source":"Health Affairs","summary":"Managing Uncertainty In Drug Value: Outcomes-Based Contracting Supports Value-Based Pricing - Health Affairs","headline":"Managing Uncertainty In Drug Value: Outcomes-Based Contracting Supports Value-Based Pricing","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}